Summary The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 17 countries in Africa, Asia, Europe, Latin America and the Middle East, and interventions for achieving the Global Health Sector Strategy on viral hepatitis targets-“WHO Targets” (65% reduction in HCV-related deaths, 90% reduction in new infections and 90% of infections diagnosed by 2030) […]
#!trpst#trp-gettext data-trpgettextoriginal=3381#!trpen#En savoir plus#!trpst#/trp-gettext#!trpen#
Summary Factors influencing the morbidity and mortality associated with viremic hepatitis C virus (HCV) infection change over time and place, making it difficult to compare reported estimates. Models were developed for 17 countries (Bahrain, Bulgaria, Cameroon, Colombia, Croatia, Dominican Republic, Ethiopia, Ghana, Hong Kong, Jordan, Kazakhstan, Malaysia, Morocco, Nigeria, Qatar and Taiwan) to quantify and […]
#!trpst#trp-gettext data-trpgettextoriginal=3381#!trpen#En savoir plus#!trpst#/trp-gettext#!trpen#
Summary Due to the introduction of newer, more efficacious treatment options, there is a pressing need for policy makers and public health officials to develop or adapt national hepatitis C virus (HCV) control strategies to the changing epidemiological landscape. To do so, detailed, country-specific data are needed to characterize the burden of chronic HCV infection. […]
#!trpst#trp-gettext data-trpgettextoriginal=3381#!trpen#En savoir plus#!trpst#/trp-gettext#!trpen#
French 
English 
Spanish 
Russian 
Arabic